Authors: Zost, Seth J.; Gilchuk, Pavlo; Chen, Rita E.; Case, James Brett; Reidy, Joseph X.; Trivette, Andrew; Nargi, Rachel S.; Sutton, Rachel E.; Suryadevara, Naveenchandra; Chen, Elaine C.; Binshtein, Elad; Shrihari, Swathi; Ostrowski, Mario; Chu, Helen Y.; Didier, Jonathan E.; MacRenaris, Keith W.; Jones, Taylor; Day, Samuel; Myers, Luke; Lee, F. Eun-Hyung; Nguyen, Doan C.; Sanz, Ignacio; Martinez, David R.; Rothlauf, Paul W.; Bloyet, Louis-Marie; Whelan, Sean; Baric, Ralph S.; Thackray, Larissa B.; Diamond, Michael S.; Carnahan, Robert H.; Crowe, James E. Jr.; crowe
Venue: Nature Medicine
Type: Publication
Abstract: Antibodies are a principal determinant of immunity for most RNA viruses and have promise to reduce infection or disease during major epidemics. The novel coronavirus SARS-CoV-2 has caused a global pandemic with millions of infections and hundreds of thousands of deaths to date1,2. In response, we used a rapid antibody discovery platform to isolate hundreds of human monoclonal antibodies (mAbs) against the SARS-CoV-2 spike (S) protein. We stratify these mAbs into five major classes based on their reactivity to subdomains of S protein as well as ...
(read more)
Impact:
3.8937165E-7
2.8345621E-8
468
414
/ Attention:
0
25
Topics: 
SARS-CoV-2 and COVID-19 Research
Viral gastroenteritis research and epidemiology
Viral Infections and Immunology Research
Loading (it may take a couple of seconds)...
Loading (it may take a couple of seconds)...
Loading (it may take a couple of seconds)...
Loading (it may take a couple of seconds)...